{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:01:16Z","timestamp":1792130476162,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024188","name":"National Youth Council Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ebiom.2025.105822","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T08:21:58Z","timestamp":1751703718000},"page":"105822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinations"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1113-6128","authenticated-orcid":false,"given":"J\u00e9r\u00e9mie","family":"Decalf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangeline","family":"Toy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Kenkre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Berkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Seir","family":"Kee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srividya","family":"Myneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ebtikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Ancheta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-2291","authenticated-orcid":false,"given":"Hok Seon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nga","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debarko","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"McLerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautham K.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Betzenhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7793-3931","authenticated-orcid":false,"given":"Wilson","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Meric","family":"Ovacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shomyseh","family":"Sanjabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Comps-Agrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivan","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Kemball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-773X","authenticated-orcid":false,"given":"Iraj","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Schartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7771-7574","authenticated-orcid":false,"given":"Travis W.","family":"Bainbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1641-4094","authenticated-orcid":false,"given":"Christine","family":"Moussion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ebiom.2025.105822_bib1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1084\/jem.137.5.1142","article-title":"Identification of a novel cell type in peripheral lymphoid organs of mice","volume":"137","author":"Steinman","year":"1973","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2025.105822_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","article-title":"Dendritic cells revisited","volume":"39","author":"Cabeza-Cabrerizo","year":"2021","journal-title":"Annu Rev Immunol"},{"issue":"6335","key":"10.1016\/j.ebiom.2025.105822_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105822_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cell.2019.09.035","article-title":"Transcriptional basis of mouse and human dendritic cell heterogeneity","volume":"179","author":"Brown","year":"2019","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105822_bib5","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The role of type 1 conventional dendritic cells in cancer immunity","volume":"4","author":"B\u00f6ttcher","year":"2018","journal-title":"Trends Cancer"},{"issue":"70","key":"10.1016\/j.ebiom.2025.105822_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abm9409","article-title":"Human dendritic cells in cancer","volume":"7","author":"Kvedaraite","year":"2022","journal-title":"Sci Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20100348","article-title":"Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells","volume":"207","author":"Bachem","year":"2010","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105822_bib8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.192.12.1685","article-title":"Cd8+ but not Cd8\u2212 dendritic cells cross-prime cytotoxic T cells in vivo","volume":"192","author":"den Haan","year":"2000","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105822_bib9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103+\/CD141+ dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"issue":"5904","key":"10.1016\/j.ebiom.2025.105822_bib10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8\u03b1+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105822_bib11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-Residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105822_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","article-title":"Unleashing type-2 dendritic cells to drive protective antitumor CD4+ T cell immunity","volume":"177","author":"Binnewies","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105822_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.immuni.2021.10.020","article-title":"Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity","volume":"55","author":"Duong","year":"2022","journal-title":"Immunity"},{"issue":"7917","key":"10.1016\/j.ebiom.2025.105822_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41586-022-04866-z","article-title":"Ablation of cDC2 development by triple mutations within the Zeb2 enhancer","volume":"607","author":"Liu","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105822_bib15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105822_bib16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ccell.2014.09.007","article-title":"Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity","volume":"26","author":"Broz","year":"2014","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105822_bib17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41590-018-0145-8","article-title":"Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific","volume":"19","author":"Michea","year":"2018","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105822_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105822_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1158\/2159-8290.CD-15-0510","article-title":"Cancer immunotherapy with immunomodulatory anti-CD137 and anti\u2013PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells","volume":"6","author":"S\u00e1nchez-Paulete","year":"2016","journal-title":"Cancer Discov"},{"issue":"534","key":"10.1016\/j.ebiom.2025.105822_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7431","article-title":"Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy","volume":"12","author":"Mayoux","year":"2020","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib21","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(93)90325-K","article-title":"Molecular cloning of a ligand for the flt3flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells","volume":"75","author":"Lyman","year":"1993","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105822_bib22","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood.V95.11.3489","article-title":"Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells","volume":"95","author":"McKenna","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105822_bib23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1084\/jem.20171784","article-title":"Altered compensatory cytokine signaling underlies the discrepancy between Flt3\u2013\/\u2013 and Flt3l\u2013\/\u2013 miceEnhanced cytokine signaling supports Flt3\u2212\/\u2212 DCs","volume":"215","author":"Durai","year":"2018","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105822_bib24","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1084\/jem.184.5.1953","article-title":"Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified","volume":"184","author":"Maraskovsky","year":"1996","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105822_bib25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/bmt.2015.74","article-title":"Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers","volume":"50","author":"Anandasabapathy","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nm0697-625","article-title":"Flt3 ligand induces tumor regression and antitumor immune responses in vivo","volume":"3","author":"Lynch","year":"1997","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105822_bib27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105822_bib28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41591-019-0410-x","article-title":"Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination","volume":"25","author":"Hammerich","year":"2019","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105822_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccell.2020.02.008","article-title":"Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer","volume":"37","author":"Hegde","year":"2020","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105822_bib30","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190673","article-title":"Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis","volume":"217","author":"Lin","year":"2020","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105822_bib31","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41467-020-19192-z","article-title":"Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s","volume":"11","author":"Oba","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105822_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071525","article-title":"The Flt3L\/flt3 axis in dendritic cell biology and cancer immunotherapy","volume":"13","author":"Cueto","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105822_bib33","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.4049\/jimmunol.0801931","article-title":"Ectodomain shedding of FLT3 ligand is mediated by TNF-\u03b1 converting enzyme","volume":"182","author":"Horiuchi","year":"2009","journal-title":"J Immunol"},{"issue":"29","key":"10.1016\/j.ebiom.2025.105822_bib34","doi-asserted-by":"crossref","first-page":"14714","DOI":"10.1073\/pnas.1818907116","article-title":"Cell-autonomous FLT3L shedding via ADAM10 mediates conventional dendritic cell development in mouse spleen","volume":"116","author":"Fujita","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"28","key":"10.1016\/j.ebiom.2025.105822_bib35","doi-asserted-by":"crossref","first-page":"17626","DOI":"10.1074\/jbc.273.28.17626","article-title":"Structure-function analysis of FLT3 ligand-FLT3 receptor interactions using a rapid functional screen\u2217","volume":"273","author":"Graddis","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2025.105822_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jim.2014.07.008","article-title":"Robust expansion of dendritic cells in vivo by hydrodynamic FLT3L-FC gene transfer","volume":"413","author":"Tu","year":"2014","journal-title":"J Immunol Methods"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105822_bib37","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4161\/mabs.29835","article-title":"Monomeric IgG1 Fc molecules displaying unique Fc receptor interactions that are exploitable to treat inflammation-mediated diseases","volume":"6","author":"Ying","year":"2014","journal-title":"MAbs"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105822_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244158","article-title":"Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology","volume":"15","author":"Lin","year":"2020","journal-title":"Plos One"},{"issue":"43","key":"10.1016\/j.ebiom.2025.105822_bib39","doi-asserted-by":"crossref","first-page":"30843","DOI":"10.1074\/jbc.M113.486142","article-title":"Engineered protease-resistant antibodies with selectable cell-killing functions\u2217","volume":"288","author":"Kinder","year":"2013","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105822_bib40","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/19420862.2015.1022692","article-title":"An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions","volume":"7","author":"Kinder","year":"2015","journal-title":"MAbs"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105822_bib41","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.4049\/jimmunol.1401243","article-title":"Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells","volume":"193","author":"Balan","year":"2014","journal-title":"J Immunol"},{"issue":"10066","key":"10.1016\/j.ebiom.2025.105822_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","article-title":"Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial","volume":"389","author":"Rittmeyer","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105822_bib43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1517\/14712598.2016.1165661","article-title":"Half-life extended biotherapeutics","volume":"16","author":"Kontermann","year":"2016","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib44","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4161\/mabs.26436","article-title":"Effects of altered Fc\u03b3R binding on antibody pharmacokinetics in cynomolgus monkeys","volume":"5","author":"Leabman","year":"2013","journal-title":"MAbs"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105822_bib45","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J","article-title":"Recombinant human IgG molecules lacking Fcgamma receptor I binding and monocyte triggering activities","volume":"29","author":"Armour","year":"1999","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105822_bib46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2011-01-329532","article-title":"Structural insights into the extracellular assembly of the hematopoietic Flt3 signaling complex","volume":"118","author":"Verstraete","year":"2011","journal-title":"Blood"},{"issue":"10\u201312","key":"10.1016\/j.ebiom.2025.105822_bib47","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00726-019-02787-2","article-title":"Susceptibility of protein therapeutics to spontaneous chemical modifications by oxidation, cyclization, and elimination reactions","volume":"51","author":"Grassi","year":"2019","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105822_bib48","first-page":"261","article-title":"Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells","volume":"10","author":"Dehmel","year":"1996","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105822_bib49","first-page":"765","article-title":"Expression and function of Flt3\/flk2 in human tumor cell lines","volume":"14","author":"Serve","year":"1999","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105822_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.leu.2402740","article-title":"FLT3 mutations in acute myeloid leukemia cell lines","volume":"17","author":"Quentmeier","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.ebiom.2025.105822_bib51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2016.01.005","article-title":"N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins","volume":"100","author":"Higel","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105822_bib52","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105822_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2025.105822_bib54","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fimmu.2018.00350","article-title":"Mechanisms of tolerance induction by dendritic cells in vivo","volume":"9","author":"Hasegawa","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib55","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.4049\/jimmunol.1601629","article-title":"The importance of dendritic cells in maintaining immune tolerance","volume":"198","author":"Audiger","year":"2017","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105822_bib56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bj.2017.01.002","article-title":"Harnessing the properties of dendritic cells in the pursuit of immunological tolerance","volume":"40","author":"Horton","year":"2017","journal-title":"Biomed J"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105822_bib57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-065X.2008.00718.x","article-title":"Inflammatory signals in dendritic cell activation and the induction of adaptive immunity","volume":"227","author":"Joffre","year":"2009","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105822_bib58","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.4049\/jimmunol.181.4.2694","article-title":"Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5\/RIG-I-mediated differential signaling","volume":"181","author":"Kalali","year":"2008","journal-title":"J Immunol"},{"issue":"7802","key":"10.1016\/j.ebiom.2025.105822_bib59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"issue":"83","key":"10.1016\/j.ebiom.2025.105822_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add3955","article-title":"LXR signaling controls homeostatic dendritic cell maturation","volume":"8","author":"Bosteels","year":"2023","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105822_bib61","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1038\/s41467-022-34791-8","article-title":"Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity","volume":"13","author":"Svensson-Arvelund","year":"2022","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib62","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"de Mingo Pulido","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105822_bib63","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","article-title":"Low dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy","volume":"12","author":"Herrera","year":"2021","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib64","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","article-title":"Intratumoral dendritic cell\u2013CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma","volume":"29","author":"Magen","year":"2023","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib65","article-title":"Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo","volume":"6","author":"Marraco","year":"2011","journal-title":"Plos One"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105822_bib66","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.20030323","article-title":"Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo","volume":"198","author":"Karsunky","year":"2003","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib67","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105822_bib68","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib69","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105822_bib70","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s43018-020-00143-y","article-title":"Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets","volume":"1","author":"Bhardwaj","year":"2020","journal-title":"Nat Cancer"},{"issue":"24","key":"10.1016\/j.ebiom.2025.105822_bib71","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-21-0939","article-title":"Neoadjuvant in situ immunomodulation enhances systemic antitumor immunity against highly metastatic tumors","volume":"81","author":"Oba","year":"2021","journal-title":"Cancer Res"},{"issue":"17","key":"10.1016\/j.ebiom.2025.105822_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179401","article-title":"Immune checkpoint therapy: tumor draining lymph nodes in the spotlights","volume":"22","author":"Fransen","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib73","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210749","article-title":"In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue","volume":"219","author":"Li","year":"2022","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105822_bib74","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s43018-022-00447-1","article-title":"Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through Fc\u03b3R engagement and type I interferon signaling","volume":"3","author":"Yofe","year":"2022","journal-title":"Nat Cancer"},{"issue":"84","key":"10.1016\/j.ebiom.2025.105822_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add7446","article-title":"Rapid recruitment and IFN-I\u2013mediated activation of monocytes dictate focal radiotherapy efficacy","volume":"8","author":"Tadepalli","year":"2023","journal-title":"Sci Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105822_bib76","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ccell.2023.04.018","article-title":"Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105822_bib77","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s43018-020-0075-x","article-title":"PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer","volume":"1","author":"Oh","year":"2020","journal-title":"Nat Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105822_bib78","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105822_bib79","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0006-291X(78)91322-0","article-title":"Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril","volume":"80","author":"Fraker","year":"1978","journal-title":"Biochem Biophys Res Commun"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500266X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500266X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:03:48Z","timestamp":1755497028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642500266X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":79,"alternative-id":["S235239642500266X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105822","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinations","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105822"}}